Proteas Bioanalytics, the biotech startup focused any disease from a single drop of blood, has raised $350K in funding according to a recent SEC filing. The filing indicates that the total offering is for $4M and that this close comes from three investors. Proteas Bioanalytics was founded by Spiros D. Garbis in 2020.
MarketplaceLIVE is the place where the complete community of cloud and internet stakeholders can come together to learn, cross-pollinate ideas, and get inspired in an immersive, global and digital environment, happening this Thursday, November 19, 2020. Through inspiring keynotes and tailored content tracks, attendees from differing roles and backgrounds will be able to gain valuable knowledge and insights that most resonate with them, whether they are a network engineer at a startup, a solutions architect at a cloud service provider, or a CIO at a Fortune 500 company. REGISTER NOW FOR FREE